CXCL8 and allergic disease: Accordingly, in our in vitro model we clearly identified that the stimulation with rhIL-17A promotes the release of IL-8 in both nasal and bronchial epithelial cells suggesting that IL-17A might cause the IL-8 mediated airway inflammation in the allergic disease of the nose and of the bronchi.